Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Nike Inc. Will Stop Using Kangaroo Skins For Its Nike Tiempo And All Other Shoes In 2023

– Reuters

byHappy Mohamed

March 14, 2023

1 minute read

– Reuters

OncoSec Announces Pricing Of $3.5M Public Offering

By Benzinga Newsdesk

Today, 8:42 AM

OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune system to target and eradicate cancer, today announced the pricing of its "reasonable best effo

ONCS

Did Umbilical Cord Blood Transplant Help Cure A Woman’s HIV infection?

By Vandana Singh

Today, 8:42 AM

A woman in the New York City area appears to have been cured of an HIV infection, Wall Street Journal reported, provid

Inflation, Pressure on Consumers’ Discretionary Spending Bite Into Signet Jewelers’ Future Outlook

By Shivani Kumaresan

Today, 8:42 AM

Diamond jewelry retailer Signet Jewelers Ltd (NYSE:SIG) reported a second-quarter FY23 sales decline of 1.9% year-on-year to $1.755 billion, marginally beating the…

SIG

HC Wainwright & Co. Maintains Buy on Deciphera Pharmaceuticals, Lowers Price Target to $15

By Benzinga Newsdesk

Today, 8:42 AM

HC Wainwright & Co. analyst Andrew Fein maintains Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy and lowers the price target from $25 to $15.

DCPH

Nike Inc. Will Stop Using Kangaroo Skins For Its Nike Tiempo And All Other Shoes In 2023

Related Posts

OncoSec Announces Pricing Of $3.5M Public Offering

Did Umbilical Cord Blood Transplant Help Cure A Woman’s HIV infection?

Inflation, Pressure on Consumers’ Discretionary Spending Bite Into Signet Jewelers’ Future Outlook

HC Wainwright & Co. Maintains Buy on Deciphera Pharmaceuticals, Lowers Price Target to $15